European Salk Institute
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
Public pharma for Europe, a game-changer for access to medicines
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
